DiaMedica Therapeutics Ownership 2024 | Who Owns DiaMedica Therapeutics Now?

Overview Forecast RevenueFinancials Chart Transcripts

Institutional Ownership

12.38%

Insider Ownership

26.47%

Retail Ownership

61.15%

Institutional Holders

19.00

DiaMedica Therapeutics Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
COOPERMAN LEON G	3.69%	0.17%	1,400,000	516,377	58.44%	4,130,000	Jun 30, 2024
VANGUARD GROUP INC	2.68%	0.00%	1,017,402	3,880	0.38%	3,001,336	Jun 30, 2024
FIRST MANHATTAN CO. LLC.	2.21%	0.01%	839,081	-10,957	-1.29%	2,475,289	Jun 30, 2024
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE	1.27%	3.48%	482,614	-17,386	-3.48%	1,423,711	Jun 30, 2024
BLEICHROEDER LP	1.01%	0.34%	382,317	160,000	71.97%	1,127,835	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	0.62%	0.00%	236,888	-2,347	-0.98%	698,996	Jun 30, 2024
NORTHERN TRUST CORP	0.32%	0.00%	120,389	-7,430	-5.81%	355,148,000	Jun 30, 2024
BLACKROCK INC.	0.28%	-	105,303	1,933	1.87%	310,644	Jun 30, 2024
MORGAN STANLEY	0.23%	-	86,200	-5,373	-5.87%	254,290	Jun 30, 2024
STATE STREET CORP	0.18%	-	68,729	2,100	3.15%	202,751,000	Jun 30, 2024
CATALYST FINANCIAL PARTNERS LLC	0.10%	0.02%	38,457	2,190	6.04%	113,448	Jun 30, 2024
MAGNOLIA CAPITAL ADVISORS LLC	0.08%	0.00%	29,500	29,500	100.00%	10,000	Jun 30, 2024
STONEBRIDGE CAPITAL ADVISORS LLC	0.05%	0.01%	20,000	-	-	59,000	Jun 30, 2024
LPL FINANCIAL LLC	0.05%	-	17,500	17,500	100.00%	51,625	Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP	0.04%	-	16,959	-	-	50,030	Jun 30, 2024
BNP PARIBAS ARBITRAGE, SNC	0.04%	-	15,200	700	4.83%	44,840	Jun 30, 2024
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	0.03%	-	13,251	-	-	39,090	Jun 30, 2024
US BANCORP \DE\	0.01%	-	4,335	-	-	12,788	Jun 30, 2024
NAPLES MONEY MANAGEMENT LLC	0.01%	0.01%	2,978	-	-	8,785	Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.	0.01%	-	2,055	1,055	105.50%	6,062	Jun 30, 2024

DiaMedica Therapeutics's largest institutional shareholder is COOPERMAN LEON G, holding 3.69% of the company's total share outstanding, currently valued at $4.13M. The top 10 institutional shareholders own together 12.48% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE	1.27%	3.48%	482,614	-17,386	-3.48%	1,423,711	Jun 30, 2024
BLEICHROEDER LP	1.01%	0.34%	382,317	160,000	71.97%	1,127,835	Jun 30, 2024
COOPERMAN LEON G	3.69%	0.17%	1,400,000	516,377	58.44%	4,130,000	Jun 30, 2024
CATALYST FINANCIAL PARTNERS LLC	0.10%	0.02%	38,457	2,190	6.04%	113,448	Jun 30, 2024
FIRST MANHATTAN CO. LLC.	2.21%	0.01%	839,081	-10,957	-1.29%	2,475,289	Jun 30, 2024
NAPLES MONEY MANAGEMENT LLC	0.01%	0.01%	2,978	-	-	8,785	Jun 30, 2024
STONEBRIDGE CAPITAL ADVISORS LLC	0.05%	0.01%	20,000	-	-	59,000	Jun 30, 2024
MAGNOLIA CAPITAL ADVISORS LLC	0.08%	0.00%	29,500	29,500	100.00%	10,000	Jun 30, 2024
LEGEND FINANCIAL ADVISORS, INC.	0.00%	0.00%	1,000	-	-	2,950	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.01%	0.00%	1,888	-808	-29.97%	5,570	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	0.62%	0.00%	236,888	-2,347	-0.98%	698,996	Jun 30, 2024
NORTHERN TRUST CORP	0.32%	0.00%	120,389	-7,430	-5.81%	355,148,000	Jun 30, 2024
VANGUARD GROUP INC	2.68%	0.00%	1,017,402	3,880	0.38%	3,001,336	Jun 30, 2024
BNP PARIBAS ARBITRAGE, SNC	0.04%	-	15,200	700	4.83%	44,840	Jun 30, 2024
TD WATERHOUSE CANADA INC.	0.00%	-	1,070	-	-	4,174	Jun 30, 2024
LPL FINANCIAL LLC	0.05%	-	17,500	17,500	100.00%	51,625	Jun 30, 2024
MORGAN STANLEY	0.23%	-	86,200	-5,373	-5.87%	254,290	Jun 30, 2024
US BANCORP \DE\	0.01%	-	4,335	-	-	12,788	Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.	0.01%	-	2,055	1,055	105.50%	6,062	Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP	0.04%	-	16,959	-	-	50,030	Jun 30, 2024

The largest DiaMedica Therapeutics shareholder by % of total assets is PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE. The company owns 482.61K shares of DiaMedica Therapeutics (DMAC), representing 3.48% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
COOPERMAN LEON G	3.69%	0.17%	1,400,000	516,377	58.44%	4,130,000	Jun 30, 2024
BLEICHROEDER LP	1.01%	0.34%	382,317	160,000	71.97%	1,127,835	Jun 30, 2024
MAGNOLIA CAPITAL ADVISORS LLC	0.08%	0.00%	29,500	29,500	100.00%	10,000	Jun 30, 2024
LPL FINANCIAL LLC	0.05%	-	17,500	17,500	100.00%	51,625	Jun 30, 2024
VANGUARD GROUP INC	2.68%	0.00%	1,017,402	3,880	0.38%	3,001,336	Jun 30, 2024
CATALYST FINANCIAL PARTNERS LLC	0.10%	0.02%	38,457	2,190	6.04%	113,448	Jun 30, 2024
STATE STREET CORP	0.18%	-	68,729	2,100	3.15%	202,751,000	Jun 30, 2024
BLACKROCK INC.	0.28%	-	105,303	1,933	1.87%	310,644	Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.	0.01%	-	2,055	1,055	105.50%	6,062	Jun 30, 2024
BNP PARIBAS ARBITRAGE, SNC	0.04%	-	15,200	700	4.83%	44,840	Jun 30, 2024
ROYAL BANK OF CANADA	0.00%	-	1,056	211	24.97%	3,000	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.00%	-	183	183	100.00%	540	Jun 30, 2024
TORONTO DOMINION BANK	0.00%	-	24	-	-	71	Jun 30, 2024
FEDERATION DES CAISSES DESJARDINS DU QUEBEC	0.00%	-	230	-	-	679	Jun 30, 2024
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	0.03%	-	13,251	-	-	39,090	Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP	0.04%	-	16,959	-	-	50,030	Jun 30, 2024
US BANCORP \DE\	0.01%	-	4,335	-	-	12,788	Jun 30, 2024
TD WATERHOUSE CANADA INC.	0.00%	-	1,070	-	-	4,174	Jun 30, 2024
LEGEND FINANCIAL ADVISORS, INC.	0.00%	0.00%	1,000	-	-	2,950	Jun 30, 2024
STONEBRIDGE CAPITAL ADVISORS LLC	0.05%	0.01%	20,000	-	-	59,000	Jun 30, 2024

As of Jun 30 2024, DiaMedica Therapeutics's largest institutional buyer is COOPERMAN LEON G. The company purchased 516.38K stocks of DMAC, valued at $4.13M.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ARISTIDES CAPITAL LLC	-	-	-	-106,333	-100.00%	-	Jun 30, 2024
BANK OF NEW YORK MELLON CORP	-	-	-	-24,000	-100.00%	-	Jun 30, 2024
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE	1.27%	3.48%	482,614	-17,386	-3.48%	1,423,711	Jun 30, 2024
FIRST MANHATTAN CO. LLC.	2.21%	0.01%	839,081	-10,957	-1.29%	2,475,289	Jun 30, 2024
NORTHERN TRUST CORP	0.32%	0.00%	120,389	-7,430	-5.81%	355,148,000	Jun 30, 2024
MORGAN STANLEY	0.23%	-	86,200	-5,373	-5.87%	254,290	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	0.62%	0.00%	236,888	-2,347	-0.98%	698,996	Jun 30, 2024
UBS GROUP AG	-	-	-	-1,926	-100.00%	-	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.01%	0.00%	1,888	-808	-29.97%	5,570	Jun 30, 2024
WELLS FARGO & COMPANY/MN	-	-	-	-175	-100.00%	-	Jun 30, 2024
NAPLES MONEY MANAGEMENT LLC	0.01%	0.01%	2,978	-	-	8,785	Jun 30, 2024
STONEBRIDGE CAPITAL ADVISORS LLC	0.05%	0.01%	20,000	-	-	59,000	Jun 30, 2024
LEGEND FINANCIAL ADVISORS, INC.	0.00%	0.00%	1,000	-	-	2,950	Jun 30, 2024
TD WATERHOUSE CANADA INC.	0.00%	-	1,070	-	-	4,174	Jun 30, 2024
US BANCORP \DE\	0.01%	-	4,335	-	-	12,788	Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP	0.04%	-	16,959	-	-	50,030	Jun 30, 2024
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	0.03%	-	13,251	-	-	39,090	Jun 30, 2024
FEDERATION DES CAISSES DESJARDINS DU QUEBEC	0.00%	-	230	-	-	679	Jun 30, 2024
TORONTO DOMINION BANK	0.00%	-	24	-	-	71	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.00%	-	183	183	100.00%	540	Jun 30, 2024

As of Jun 30 2024, DiaMedica Therapeutics's biggest institutional seller is ARISTIDES CAPITAL LLC. The company sold -0.11M shares of DMAC, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
MAGNOLIA CAPITAL ADVISORS LLC	0.08%	0.00%	29,500	29,500	100.00%	10,000	Jun 30, 2024
LPL FINANCIAL LLC	0.05%	-	17,500	17,500	100.00%	51,625	Jun 30, 2024

DiaMedica Therapeutics's largest new institutional shareholder by number of shares is MAGNOLIA CAPITAL ADVISORS LLC, purchased 29.50K shares, valued at $10.00K, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ARISTIDES CAPITAL LLC	-	-	-	-106,333	-100.00%	-	Jun 30, 2024
BANK OF NEW YORK MELLON CORP	-	-	-	-24,000	-100.00%	-	Jun 30, 2024
UBS GROUP AG	-	-	-	-1,926	-100.00%	-	Jun 30, 2024
WELLS FARGO & COMPANY/MN	-	-	-	-175	-100.00%	-	Jun 30, 2024

DiaMedica Therapeutics's largest sold out institutional shareholder by shares sold is ARISTIDES CAPITAL LLC, sold -0.11M shares, valued at -, as of undefined.

DiaMedica Therapeutics Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
Jacob Funds Inc.	0.61%	140,730	-25,000	-15.08%	Feb 29, 2024
VANGUARD VALLEY FORGE FUNDS	0.05%	24,554	-	-	Mar 31, 2024
VANGUARD INDEX FUNDS	0.00%	965,424	-36,451	-3.64%	Mar 31, 2024
AdvisorShares Trust	0.00%	3,937	-	-	Mar 28, 2024
FIDELITY CONCORD STREET TRUST	0.00%	204,754	1,363	0.67%	Feb 29, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS	0.00%	15,764	-	-	Mar 31, 2024
SCHWAB CAPITAL TRUST	0.00%	13,251	-	-	Jan 31, 2024
NORTHERN FUNDS	0.00%	20,810	-	-	Mar 28, 2024
AMERICAN CENTURY ETF TRUST	0.00%	3,243	-	-	Feb 29, 2024
DFA INVESTMENT DIMENSIONS GROUP INC	0.00%	25,675	-	-	Jan 31, 2024
USAA MUTUAL FUNDS TRUST	0.00%	2,585	-	-	Jan 31, 2024
EQ ADVISORS TRUST	0.00%	4,111	6	0.15%	Mar 31, 2024
iSHARES TRUST	0.00%	51,999	-1,368	-2.56%	Mar 31, 2024
Blackstone Alternative Investment Funds	0.00%	100	-	-	Mar 31, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST	0.00%	576	279	93.94%	Mar 31, 2024

DiaMedica Therapeutics's largest mutual fund holder by % of total assets is "Jacob Funds Inc.", owning 140.73K shares, compromising 0.61% of its total assets.

DiaMedica Therapeutics Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
30 Jun, 24	19	-44.12%
31 Mar, 24	34	-12.82%
31 Dec, 23	39	2.63%
30 Sep, 23	38	18.75%
30 Jun, 23	32	28.00%
31 Mar, 23	25	-16.67%
31 Dec, 22	30	25.00%
30 Sep, 22	24	-7.69%
30 Jun, 22	26	-16.13%
31 Mar, 22	31	-18.42%
31 Dec, 21	38	11.76%
30 Sep, 21	34	-19.05%
30 Jun, 21	42	10.53%
31 Mar, 21	38	15.15%
31 Dec, 20	33	13.79%
30 Sep, 20	29	45.00%
30 Jun, 20	20	11.11%
31 Mar, 20	18	50.00%
31 Dec, 19	12	-7.69%
30 Sep, 19	13	-13.33%
30 Jun, 19	15	50.00%
31 Mar, 19	10	42.86%
31 Dec, 18	7	-

As of 30 Jun 24, 19 institutions are holding DiaMedica Therapeutics's shares, representing a decrease of -44.12% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
30 Jun, 24	4,698,687	2.16%
31 Mar, 24	4,599,129	19.70%
31 Dec, 23	3,842,355	-9.61%
30 Sep, 23	4,251,040	21.78%
30 Jun, 23	3,490,688	35.95%
31 Mar, 23	2,567,587	1.69%
31 Dec, 22	2,524,815	-0.19%
30 Sep, 22	2,529,604	-31.09%
30 Jun, 22	3,670,682	-8.40%
31 Mar, 22	4,007,184	0.30%
31 Dec, 21	3,995,170	42.45%
30 Sep, 21	2,804,615	-25.88%
30 Jun, 21	3,784,020	-33.47%
31 Mar, 21	5,687,728	-4.85%
31 Dec, 20	5,977,430	-6.98%
30 Sep, 20	6,426,029	112.17%
30 Jun, 20	3,028,667	3.58%
31 Mar, 20	2,923,902	265.06%
31 Dec, 19	800,946	-15.14%
30 Sep, 19	943,841	-26.47%
30 Jun, 19	1,283,634	26.70%
31 Mar, 19	1,013,152	-1.88%
31 Dec, 18	1,032,562	-

DiaMedica Therapeutics (DMAC) has 4.70M shares outstanding as of 30 Jun 24, up 2.16% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
30 Jun, 24	12.38%	6.21%
31 Mar, 24	14.12%	13.78%
31 Dec, 23	10.12%	4.18%
30 Sep, 23	15.56%	8.94%
30 Jun, 23	13.20%	14.00%
31 Mar, 23	9.71%	10.65%
31 Dec, 22	9.55%	10.43%
30 Sep, 22	9.57%	4.96%
30 Jun, 22	13.88%	6.04%
31 Mar, 22	15.15%	4.10%
31 Dec, 21	19.23%	8.86%
30 Sep, 21	14.73%	3.63%
30 Jun, 21	20.14%	2.19%
31 Mar, 21	30.31%	2.09%
31 Dec, 20	38.12%	2.57%
30 Sep, 20	38.50%	8.39%
30 Jun, 20	21.42%	4.30%
31 Mar, 20	22.31%	49.97%
31 Dec, 19	6.68%	10.81%
30 Sep, 19	7.86%	6.85%
30 Jun, 19	10.72%	14.92%
31 Mar, 19	8.47%	11.36%
31 Dec, 18	8.64%	-

As of 30 Jun 24, DiaMedica Therapeutics is held by 12.38% institutional shareholders, representing a 6.21% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
30 Jun, 24	8	-11.11%
31 Mar, 24	9	-50.00%
31 Dec, 23	18	-10.00%
30 Sep, 23	20	25.00%
30 Jun, 23	16	77.78%
31 Mar, 23	9	-40.00%
31 Dec, 22	15	50.00%
30 Sep, 22	10	25.00%
30 Jun, 22	8	-20.00%
31 Mar, 22	10	-47.37%
31 Dec, 21	19	26.67%
30 Sep, 21	15	-31.82%
30 Jun, 21	22	-12.00%
31 Mar, 21	25	19.05%
31 Dec, 20	21	-12.50%
30 Sep, 20	24	166.67%
30 Jun, 20	9	-30.77%
31 Mar, 20	13	116.67%
31 Dec, 19	6	-14.29%
30 Sep, 19	7	-30.00%
30 Jun, 19	10	42.86%
31 Mar, 19	7	-
31 Dec, 18	7	-

8 institutional shareholders have increased their position in DMAC stock as of 30 Jun 24 compared to 9 in the previous quarter (a -11.11% decrease).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
30 Jun, 24	5	-37.50%
31 Mar, 24	8	100.00%
31 Dec, 23	4	-42.86%
30 Sep, 23	7	40.00%
30 Jun, 23	5	25.00%
31 Mar, 23	4	-33.33%
31 Dec, 22	6	-
30 Sep, 22	6	-
30 Jun, 22	6	-50.00%
31 Mar, 22	12	71.43%
31 Dec, 21	7	-41.67%
30 Sep, 21	12	50.00%
30 Jun, 21	8	-
31 Mar, 21	8	60.00%
31 Dec, 20	5	150.00%
30 Sep, 20	2	-60.00%
30 Jun, 20	5	150.00%
31 Mar, 20	2	-
31 Dec, 19	2	-50.00%
30 Sep, 19	4	100.00%
30 Jun, 19	2	-
31 Mar, 19	2	-
31 Dec, 18	-	-

5 institutional shareholders have reduced their position in DMAC stock as of 30 Jun 24 compared to 8 in the previous quarter (a -37.50% decrease).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
30 Jun, 24	19	-44.12%	4,698,687	2.16%	12.38%	6.21%	8	-11.11%	5	-37.50%
31 Mar, 24	34	-12.82%	4,599,129	19.70%	14.12%	13.78%	9	-50.00%	8	100.00%
31 Dec, 23	39	2.63%	3,842,355	-9.61%	10.12%	4.18%	18	-10.00%	4	-42.86%
30 Sep, 23	38	18.75%	4,251,040	21.78%	15.56%	8.94%	20	25.00%	7	40.00%
30 Jun, 23	32	28.00%	3,490,688	35.95%	13.20%	14.00%	16	77.78%	5	25.00%
31 Mar, 23	25	-16.67%	2,567,587	1.69%	9.71%	10.65%	9	-40.00%	4	-33.33%
31 Dec, 22	30	25.00%	2,524,815	-0.19%	9.55%	10.43%	15	50.00%	6	-
30 Sep, 22	24	-7.69%	2,529,604	-31.09%	9.57%	4.96%	10	25.00%	6	-
30 Jun, 22	26	-16.13%	3,670,682	-8.40%	13.88%	6.04%	8	-20.00%	6	-50.00%
31 Mar, 22	31	-18.42%	4,007,184	0.30%	15.15%	4.10%	10	-47.37%	12	71.43%
31 Dec, 21	38	11.76%	3,995,170	42.45%	19.23%	8.86%	19	26.67%	7	-41.67%
30 Sep, 21	34	-19.05%	2,804,615	-25.88%	14.73%	3.63%	15	-31.82%	12	50.00%
30 Jun, 21	42	10.53%	3,784,020	-33.47%	20.14%	2.19%	22	-12.00%	8	-
31 Mar, 21	38	15.15%	5,687,728	-4.85%	30.31%	2.09%	25	19.05%	8	60.00%
31 Dec, 20	33	13.79%	5,977,430	-6.98%	38.12%	2.57%	21	-12.50%	5	150.00%
30 Sep, 20	29	45.00%	6,426,029	112.17%	38.50%	8.39%	24	166.67%	2	-60.00%
30 Jun, 20	20	11.11%	3,028,667	3.58%	21.42%	4.30%	9	-30.77%	5	150.00%
31 Mar, 20	18	50.00%	2,923,902	265.06%	22.31%	49.97%	13	116.67%	2	-
31 Dec, 19	12	-7.69%	800,946	-15.14%	6.68%	10.81%	6	-14.29%	2	-50.00%
30 Sep, 19	13	-13.33%	943,841	-26.47%	7.86%	6.85%	7	-30.00%	4	100.00%
30 Jun, 19	15	50.00%	1,283,634	26.70%	10.72%	14.92%	10	42.86%	2	-
31 Mar, 19	10	42.86%	1,013,152	-1.88%	8.47%	11.36%	7	-	2	-
31 Dec, 18	7	-	1,032,562	-	8.64%	-	7	-	-	-

DiaMedica Therapeutics Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jul 01, 2024	Von Koch Thomas	10 percent owner	-	P-Purchase	Buy	1,200,000	$2.50	$3.00M	5,526,435
Jul 01, 2024	STAHLBERG JAN	10 percent owner	-	P-Purchase	Buy	1,200,000	$2.50	$3.00M	5,221,608
Nov 16, 2023	Wambeke David J.	officer	Chief Business Officer	P-Purchase	Buy	20,000	$2.46	$49.20K	527,114

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jul 01, 2024	Von Koch Thomas	10 percent owner	-	P-Purchase	Buy	1,200,000	$2.50	$3.00M	5,526,435
Jul 01, 2024	STAHLBERG JAN	10 percent owner	-	P-Purchase	Buy	1,200,000	$2.50	$3.00M	5,221,608
Nov 16, 2023	Wambeke David J.	officer	Chief Business Officer	P-Purchase	Buy	20,000	$2.46	$49.20K	527,114

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jul 01, 2024	Von Koch Thomas	10 percent owner	-	P-Purchase	Buy	1,200,000	$2.50	$3.00M	5,526,435
Jul 01, 2024	STAHLBERG JAN	10 percent owner	-	P-Purchase	Buy	1,200,000	$2.50	$3.00M	5,221,608
Jun 03, 2024	Wambeke David J.	officer	Chief Business Officer	A-Award	Buy	130,000	$2.90	$377.00K	130,000
Jun 03, 2024	Kellen Scott	officer	CFO and Secretary	A-Award	Buy	130,000	$2.90	$377.00K	130,000
Jun 03, 2024	Cundari Dominic R	officer	Chief Commercial Officer	A-Award	Buy	15,000	$2.90	$43.50K	15,000
Jun 03, 2024	Pauls Dietrich John	director, officer	President and CEO	A-Award	Buy	300,000	$2.90	$870.00K	300,000
Jun 03, 2024	Semba Charles Pauling	director	-	A-Award	Buy	28,472	$2.90	$82.57K	28,472
Jun 03, 2024	Pilnik Richard D.	director	-	A-Award	Buy	36,065	$2.90	$104.59K	36,065
Jun 03, 2024	Parsons James T.	director	-	A-Award	Buy	28,472	$2.90	$82.57K	28,472
Jun 03, 2024	Lewis Tanya	director	-	A-Award	Buy	28,472	$2.90	$82.57K	28,472
Jun 03, 2024	Kuntz Richard	director	-	A-Award	Buy	28,472	$2.90	$82.57K	28,472
Jun 03, 2024	Giuffre Randall Michael	director	-	A-Award	Buy	28,472	$2.90	$82.57K	28,472
Jan 23, 2024	Lorianne Masuoka K.	officer	Chief Medical Officer	A-Award	Buy	285,000	$2.79	$795.15K	285,000
Jan 23, 2024	Lorianne Masuoka K.	officer	-		Buy	-	-	-	-
Jan 02, 2024	Semba Charles Pauling	director	-	A-Award	Buy	9,375	$2.80	$26.25K	39,318
Jan 02, 2024	Kuntz Richard	director	-	A-Award	Buy	14,285	$2.80	$40.00K	14,285
Jan 02, 2024	Pilnik Richard D.	director	-	A-Award	Buy	30,357	$2.80	$85.00K	278,602
Jan 02, 2024	Parsons James T.	director	-	A-Award	Buy	21,428	$2.80	$60.00K	59,937
Jan 02, 2024	Giuffre Randall Michael	director	-	A-Award	Buy	19,196	$2.80	$53.75K	364,551
Nov 16, 2023	Wambeke David J.	officer	Chief Business Officer	P-Purchase	Buy	20,000	$2.46	$49.20K	527,114

The last insider buy of DMAC was made by Von Koch Thomas on Jul 01 2024, buying 1,200,000 shares at $2.50 per share (worth $3.00M).

DiaMedica Therapeutics Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2024	10	-	-
Q1 2024	6	-	-
Q4 2023	1	-	-
Q2 2023	20	1	2000.00%
Q1 2023	5	1	500.00%
Q4 2022	11	1	1100.00%
Q3 2022	1	-	-
Q2 2022	11	-	-
Q1 2022	7	1	700.00%
Q3 2021	18	-	-
Q1 2021	3	-	-
Q4 2020	4	-	-
Q2 2020	10	-	-
Q4 2019	1	-	-
Q3 2019	4	-	-
Q2 2019	10	-	-
Q1 2019	1	1	100.00%
Q4 2018	8	49	16.33%

10 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by DiaMedica Therapeutics's insiders, as of Q2 2024.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2024	-	-	-
Q1 2024	-	-	-
Q4 2023	1	-	-
Q2 2023	8	-	-
Q1 2023	-	-	-
Q4 2022	11	1	1100.00%
Q3 2022	1	-	-
Q2 2022	-	-	-
Q1 2022	-	-	-
Q3 2021	9	-	-
Q1 2021	-	-	-
Q4 2020	4	-	-
Q2 2020	-	-	-
Q4 2019	-	-	-
Q3 2019	4	-	-
Q2 2019	2	-	-
Q1 2019	1	-	-
Q4 2018	8	-	-

As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of DiaMedica Therapeutics's stocks.

DiaMedica Therapeutics Peer Ownership

Ticker	Company
XFOR	X4 Pharmaceuticals, Inc.
CNTA	Centessa Pharmaceuticals plc
IOVA	Iovance Biotherapeutics, Inc.
IKT	Inhibikase Therapeutics, Inc.
DAWN	Day One Biopharmaceuticals, Inc.
SCPH	scPharmaceuticals Inc.
HOOK	HOOKIPA Pharma Inc.
MCRB	Seres Therapeutics, Inc.
TERN	Terns Pharmaceuticals, Inc.
ONCY	Oncolytics Biotech Inc.
MIST	Milestone Pharmaceuticals Inc.
LIFE	aTyr Pharma, Inc.
LYRA	Lyra Therapeutics, Inc.
GRTX	Galera Therapeutics, Inc.

DMAC Ownership FAQ

Who Owns DiaMedica Therapeutics?

DiaMedica Therapeutics is owned by institutional shareholders (12.38%), insiders (26.47%), and public (61.15%). The largest institutional shareholder of DiaMedica Therapeutics is COOPERMAN LEON G (3.69% of total shares) and the top mutual fund owner is Jacob Funds Inc. (0.61% of total shares).

Who are the major institutional shareholders of DiaMedica Therapeutics?

DiaMedica Therapeutics's major institutional shareholders are COOPERMAN LEON G, VANGUARD GROUP INC, FIRST MANHATTAN CO. LLC., PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE, and BLEICHROEDER LP. The top five shareholders own together 10.86% of the company's share outstanding.

How many DiaMedica Therapeutics shareholders are there?

As of Jun 2024, there are 19 institutional shareholders of DiaMedica Therapeutics.

What percentage of DiaMedica Therapeutics is owned by COOPERMAN LEON G?

COOPERMAN LEON G owns 1.4M shares of DiaMedica Therapeutics, representing 3.69% of the company's total shares outstanding, valued at $4.13M (as of Jun 2024).

What percentage of DiaMedica Therapeutics is owned by VANGUARD GROUP INC?

As of Jun 2024, VANGUARD GROUP INC holds 1.02M shares of DiaMedica Therapeutics (DMAC), compromising 2.68% of the company, valued at $3M.

What percentage of DiaMedica Therapeutics is owned by FIRST MANHATTAN CO. LLC?

FIRST MANHATTAN CO. LLC is the third largest holder of DiaMedica Therapeutics. The company owns 839.08K of the company's shares outstanding (worth $2.48M).